Patent ID: 7049395

Claim:
An anti-inflammatory compound comprising the following structure: X a -X 1 -X 2 -X 3 -X 4 -X 5 -X 6 wherein X a is a membrane translocation domain comprising from 6 to 15 amino acid residues; X 1 is Leu, Ala, Ile or nor-leucine (Nle); X 2 is Asp, Glu, Asn, Gln, homoserine (Hser) or 2-ketopropylalanine (2-ketopropy-A); X 3 is Trp, Phe, Tyr, 4-biphenyl-alanine (Bpa), homophenylalanine (Hphe), 2-Naphthylalanine (2-Nal), 1-Naphthylalanine (1-Nal), or cycloxexyl-alanine (Cha); X 4 is Ser, Ala, Glu, Leu, Thr, nor-leucine (Nle), or homoserine (Hser); X 5 is Trp, His, homophenylalanine (Hphe), 2-Naphthylalanine (2-Nal), 1-Naphthylalanine (1-Nal), O-benzyl serine (SeroBn), or 3-Pyridylalanine (3-Pal); and X 6 is Leu, Ala, Ile, or nor-leucine (Nle), wherein the anti-inflammatory compound is less than 100 amino acids in length.